HUTCHMED (Nasdaq/AIM: HCM) (formerly Hutchison China MediTech) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and … Meer weergeven HUTCHMED has decided to adopt a fully electronic application process for the Hong Kong Public Offering, with no printed copies of the … Meer weergeven This announcement contains forward-looking statements within the meaning of the “safe harbor” provisions of the U.S. Private … Meer weergeven The International Offering will include Shares to be offered and sold (i) pursuant to the shelf registration statement on Form F-3ASR that was filed with the SEC and became … Meer weergeven No prospectus required for the purposes of Regulation (EU) 2024/1129 (“EU Prospectus Regulation”) or Regulation (EU) … Meer weergeven WebNasdaq:US$15.50 (+0.86) HKEX:HK$23.60 (+1.20 ... 11 Apr 2024 2024 Annual Report and Notice of Annual General Meeting Read more 4 Apr 2024 HUTCHMED Initiates …
HutchMed to Raise $600 Million in Hong Kong IPO - ChinaBio® …
Web18 jun. 2024 · 本公司鼓勵香港公開發售的申請人閱覽其招股章程,並在網上透過白表eIPO服務於www.eipo.com.hk 提出申請,或透過中央結算系統EIPO服務提出申請。 香港公開 … Web18 jun. 2024 · Hutchmed (China) Ltd - Hong-Kong-based pharmaceutical company - Launches offering for listing its shares on the Main Board of the Stock Exchange of Hong … literacy education meaning
Biotech Aspirant Hutchmed Sails Full Steam Toward Hong Kong …
Web24 jun. 2024 · Biopharmaceutical company HutchMed (China) pocketed HK$4.17bn ($537.1m) this week from its Hong Kong IPO. http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1106154/recommend-news Web18 jun. 2024 · Hutchmed — recently renamed from Chi-Med, or Hutchison China MediTech — will look to raise $603 million as part of a Hong Kong IPO that serves as a … literacy education wikipedia